Literature DB >> 12704123

Kinetics of antibody response to Ehrlichia canis immunoreactive proteins.

Jere W McBride1, Richard E Corstvet, Steven D Gaunt, Charles Boudreaux, Thaya Guedry, David H Walker.   

Abstract

Immunoreactive proteins of Ehrlichia canis and Ehrlichia chaffeensis that have been characterized include a family of 28-kDa major outer membrane proteins (p28) and two large antigenically divergent surface glycoprotein orthologs. We previously demonstrated that recombinant E. canis p28 and the 140- and 200-kDa glycoproteins gp140 and gp200, respectively, react strongly with serum antibodies from suspect canine ehrlichiosis cases that were positive for E. canis by immunofluorescent antibody test and in various phases of acute or chronic infection (J. Clin. Microbiol. 39:315-322, 2001). The kinetics of the antibody response to these potentially important vaccine and immunodiagnostic candidates is not known. Acute-phase serum antibody responses to whole-cell E. canis lysates and recombinant p28, gp140, and gp200 were monitored for 6 weeks in dogs experimentally infected with E. canis. Irrespective of the inoculation route, a T-helper 1-type response was elicited to E. canis antigens consisting of immunoglobulin G2 antibodies exclusively in both acute and convalescent phases in most dogs. Analysis of immuoreactive antigens for peak intensity and relative quantity identified major immunoreactive E. canis antigens recognized early in the infection as the 19-, 37-, 75-, and 140-kDa proteins. Later in infection, additional major immunoreactive E. canis proteins were identified, including the 28-, 47-, and 95-kDa proteins and the recently identified 200-kDa glycoprotein. All dogs had developed antibody against the recombinant gp140, gp200, and p28 in the convalescent phase. Immunoreactivity and antibody response kinetics suggest that major immunoreactive proteins identified are immunodominant, but early recognition suggests increased dominance by some antigens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12704123      PMCID: PMC153292          DOI: 10.1128/IAI.71.5.2516-2524.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Antibody-mediated elimination of the obligate intracellular bacterial pathogen Ehrlichia chaffeensis during active infection.

Authors:  G M Winslow; E Yager; K Shilo; E Volk; A Reilly; F K Chu
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Cloning and sequencing of the gene for a 120-kDa immunodominant protein of Ehrlichia chaffeensis.

Authors:  X J Yu; P Crocquet-Valdes; D H Walker
Journal:  Gene       Date:  1997-01-15       Impact factor: 3.688

3.  Cellular immune responses of cattle to Cowdria ruminantium.

Authors:  D M Mwangi; D J McKeever; S M Mahan
Journal:  Dev Biol Stand       Date:  1998

4.  A DNA vaccine protects mice against the rickettsial agent Cowdria ruminantium.

Authors:  A Nyika; S M Mahan; M J Burridge; T C Mcguire; F Rurangirwa; A F Barbet
Journal:  Parasite Immunol       Date:  1998-03       Impact factor: 2.280

5.  Immunization of cattle by infection with Cowdria ruminantium elicits T lymphocytes that recognize autologous, infected endothelial cells and monocytes.

Authors:  D M Mwangi; S M Mahan; J K Nyanjui; E L Taracha; D J McKeever
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

6.  Amplification of ehrlichial DNA from dogs 34 months after infection with Ehrlichia canis.

Authors:  S Harrus; T Waner; I Aizenberg; J E Foley; A M Poland; H Bark
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

7.  Doxycycline hyclate treatment of experimental canine ehrlichiosis followed by challenge inoculation with two Ehrlichia canis strains.

Authors:  E B Breitschwerdt; B C Hegarty; S I Hancock
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

Review 8.  Molecular basis for vaccine development against anaplasmosis and babesiosis.

Authors:  G H Palmer; T F McElwain
Journal:  Vet Parasitol       Date:  1995-03       Impact factor: 2.738

9.  Comparison of PCR with other tests for early diagnosis of canine ehrlichiosis.

Authors:  Z Iqbal; W Chaichanasiriwithaya; Y Rikihisa
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

10.  Isolation of Ehrlichia canis from dogs following subcutaneous inoculation.

Authors:  S D Gaunt; R E Corstvet; C M Berry; B Brennan
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

View more
  32 in total

1.  An immunoreactive 38-kilodalton protein of Ehrlichia canis shares structural homology and iron-binding capacity with the ferric ion-binding protein family.

Authors:  C Kuyler Doyle; Xiaofeng Zhang; Vsevolod L Popov; Jere W McBride
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  Differentially expressed and secreted major immunoreactive protein orthologs of Ehrlichia canis and E. chaffeensis elicit early antibody responses to epitopes on glycosylated tandem repeats.

Authors:  C Kuyler Doyle; Kimberly A Nethery; Vsevolod L Popov; Jere W McBride
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  Immunization with Ehrlichia P28 outer membrane proteins confers protection in a mouse model of ehrlichiosis.

Authors:  Patricia A Crocquet-Valdes; Nagaraja R Thirumalapura; Nahed Ismail; Xuejie Yu; Tais B Saito; Heather L Stevenson; Colette A Pietzsch; Sunil Thomas; David H Walker
Journal:  Clin Vaccine Immunol       Date:  2011-10-26

4.  Tyrosine-phosphorylated Ehrlichia chaffeensis and Ehrlichia canis tandem repeat orthologs contain a major continuous cross-reactive antibody epitope in lysine-rich repeats.

Authors:  Jere W McBride; Xiaofeng Zhang; Abdul Wakeel; Jeeba A Kuriakose
Journal:  Infect Immun       Date:  2011-05-23       Impact factor: 3.441

5.  Histologic, serologic, and molecular analysis of persistent ehrlichiosis in a murine model.

Authors:  Juan P Olano; Gary Wen; Hui-Min Feng; Jere W McBride; David H Walker
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

6.  Molecular characterization of antibody epitopes of Ehrlichia chaffeensis ankyrin protein 200 and tandem repeat protein 47 and evaluation of synthetic immunodeterminants for serodiagnosis of human monocytotropic ehrlichiosis.

Authors:  Tian Luo; Xiaofeng Zhang; William L Nicholson; Bing Zhu; Jere W McBride
Journal:  Clin Vaccine Immunol       Date:  2009-12-02

7.  Mass spectrometric analysis of Ehrlichia chaffeensis tandem repeat proteins reveals evidence of phosphorylation and absence of glycosylation.

Authors:  Abdul Wakeel; Xiaofeng Zhang; Jere W McBride
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

8.  Sequence and phylogenetic analysis of the gp200 protein of Ehrlichia canis from dogs in Taiwan.

Authors:  Chia-Chia Huang; Yu-Chen Hsieh; Chau-Loong Tsang; Yang-Tsung Chung
Journal:  J Vet Sci       Date:  2010-12       Impact factor: 1.672

9.  An Ehrlichia chaffeensis tandem repeat protein interacts with multiple host targets involved in cell signaling, transcriptional regulation, and vesicle trafficking.

Authors:  Abdul Wakeel; Jeeba A Kuriakose; Jere W McBride
Journal:  Infect Immun       Date:  2009-03-09       Impact factor: 3.441

10.  A variable-length PCR target protein of Ehrlichia chaffeensis contains major species-specific antibody epitopes in acidic serine-rich tandem repeats.

Authors:  Tian Luo; Xiaofeng Zhang; Abdul Wakeel; Vsevolod L Popov; Jere W McBride
Journal:  Infect Immun       Date:  2008-01-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.